FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137109737> ?p ?o ?g. }

• W2137109737 endingPage "775" @default.
• W2137109737 startingPage "770" @default.
• W2137109737 abstract "In canine leishmaniosis (CanL), kidneys are affected in virtually all dogs. Treatment of CanL is limited in Europe to meglumine antimoniate and miltefosine. This study evaluated the pharmacological, toxicological, and pathological effects of both drugs in healthy beagle dogs. Four male and four female dogs were divided into two groups. The animals in Group 1 were administered an oral solution of 2% of miltefosine at 2 mg/kg b.w. once a day, for twenty-eight days. The animals in Group 2 were administered a preparation of meglumine antimoniate at 100 mg/kg b.w. subcutaneously once a day for twenty-eight days. After treatment, all dogs were followed-up for a further twenty-eight days. Dogs were observed daily and clinically examined ten times throughout the study. On days -1 and 55 a renal biopsy was performed on all dogs and analyzed by light microscopy, immunofluorescence, and electron microscopy. All the examinations failed to demonstrate any lesions in the miltefosine-treated dogs. Conversely, all the meglumine antimoniate–treated dogs demonstrated severe tubular damage, characterized by tubular cell necrosis and apoptosis. In conclusion, although no clinical signs of renal disease were evident, the use of meglumine antimoniate in the pharmacological treatment approach of CanL-affected dogs should be carefully considered." @default.
• W2137109737 created "2016-06-24" @default.
• W2137109737 creator A5013092359 @default.
• W2137109737 creator A5016242371 @default.
• W2137109737 creator A5034519293 @default.
• W2137109737 creator A5035707622 @default.
• W2137109737 creator A5041616880 @default.
• W2137109737 creator A5064566951 @default.
• W2137109737 creator A5067082936 @default.
• W2137109737 creator A5074347698 @default.
• W2137109737 date "2009-08-18" @default.
• W2137109737 modified "2023-10-16" @default.
• W2137109737 title "Administration of Miltefosine and Meglumine Antimoniate in Healthy Dogs: Clinicopathological Evaluation of the Impact on the Kidneys" @default.
• W2137109737 cites W1963508090 @default.
• W2137109737 cites W1967682844 @default.
• W2137109737 cites W1978749892 @default.
• W2137109737 cites W1984676492 @default.
• W2137109737 cites W1985088770 @default.
• W2137109737 cites W1985859195 @default.
• W2137109737 cites W1995725063 @default.
• W2137109737 cites W2034149848 @default.
• W2137109737 cites W2035606309 @default.
• W2137109737 cites W2037063107 @default.
• W2137109737 cites W2043175371 @default.
• W2137109737 cites W2050953001 @default.
• W2137109737 cites W2051764330 @default.
• W2137109737 cites W2057031709 @default.
• W2137109737 cites W2063982195 @default.
• W2137109737 cites W2068446175 @default.
• W2137109737 cites W2071675111 @default.
• W2137109737 cites W2114480545 @default.
• W2137109737 cites W2122942994 @default.
• W2137109737 cites W2131902485 @default.
• W2137109737 cites W2143730240 @default.
• W2137109737 cites W2171950352 @default.
• W2137109737 cites W2175150888 @default.
• W2137109737 cites W4233424756 @default.
• W2137109737 cites W4255346891 @default.
• W2137109737 doi "https://doi.org/10.1177/0192623309344088" @default.
• W2137109737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19690151" @default.
• W2137109737 hasPublicationYear "2009" @default.
• W2137109737 type Work @default.
• W2137109737 sameAs 2137109737 @default.
• W2137109737 citedByCount "46" @default.
• W2137109737 countsByYear W21371097372012 @default.
• W2137109737 countsByYear W21371097372013 @default.
• W2137109737 countsByYear W21371097372014 @default.
• W2137109737 countsByYear W21371097372015 @default.
• W2137109737 countsByYear W21371097372016 @default.
• W2137109737 countsByYear W21371097372017 @default.
• W2137109737 countsByYear W21371097372018 @default.
• W2137109737 countsByYear W21371097372019 @default.
• W2137109737 countsByYear W21371097372020 @default.
• W2137109737 countsByYear W21371097372021 @default.
• W2137109737 countsByYear W21371097372022 @default.
• W2137109737 countsByYear W21371097372023 @default.
• W2137109737 crossrefType "journal-article" @default.
• W2137109737 hasAuthorship W2137109737A5013092359 @default.
• W2137109737 hasAuthorship W2137109737A5016242371 @default.
• W2137109737 hasAuthorship W2137109737A5034519293 @default.
• W2137109737 hasAuthorship W2137109737A5035707622 @default.
• W2137109737 hasAuthorship W2137109737A5041616880 @default.
• W2137109737 hasAuthorship W2137109737A5064566951 @default.
• W2137109737 hasAuthorship W2137109737A5067082936 @default.
• W2137109737 hasAuthorship W2137109737A5074347698 @default.
• W2137109737 hasBestOaLocation W21371097371 @default.
• W2137109737 hasConcept C126322002 @default.
• W2137109737 hasConcept C126838900 @default.
• W2137109737 hasConcept C142724271 @default.
• W2137109737 hasConcept C143409427 @default.
• W2137109737 hasConcept C2776555147 @default.
• W2137109737 hasConcept C2776820430 @default.
• W2137109737 hasConcept C2777843234 @default.
• W2137109737 hasConcept C2778689377 @default.
• W2137109737 hasConcept C2778702967 @default.
• W2137109737 hasConcept C2780423678 @default.
• W2137109737 hasConcept C2781417161 @default.
• W2137109737 hasConcept C503630168 @default.
• W2137109737 hasConcept C71924100 @default.
• W2137109737 hasConcept C90924648 @default.
• W2137109737 hasConcept C98274493 @default.
• W2137109737 hasConceptScore W2137109737C126322002 @default.
• W2137109737 hasConceptScore W2137109737C126838900 @default.
• W2137109737 hasConceptScore W2137109737C142724271 @default.
• W2137109737 hasConceptScore W2137109737C143409427 @default.
• W2137109737 hasConceptScore W2137109737C2776555147 @default.
• W2137109737 hasConceptScore W2137109737C2776820430 @default.
• W2137109737 hasConceptScore W2137109737C2777843234 @default.
• W2137109737 hasConceptScore W2137109737C2778689377 @default.
• W2137109737 hasConceptScore W2137109737C2778702967 @default.
• W2137109737 hasConceptScore W2137109737C2780423678 @default.
• W2137109737 hasConceptScore W2137109737C2781417161 @default.
• W2137109737 hasConceptScore W2137109737C503630168 @default.
• W2137109737 hasConceptScore W2137109737C71924100 @default.
• W2137109737 hasConceptScore W2137109737C90924648 @default.
• W2137109737 hasConceptScore W2137109737C98274493 @default.
• W2137109737 hasIssue "6" @default.
• W2137109737 hasLocation W21371097371 @default.

• next